HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the immune response to a Toll-Like Receptor 9 agonist adjuvanted pneumococcal vaccine in HIV-infected a…
-
CLINICAL_TRIALS trial_result · 2009-01-15Clinical Trial Update: Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage [Phase 4]
This Phase 4 trial compares stepped dosing of efavirenz with the usual dose and reports on the incidence and severity of neuropsychiatric ad…
-
CLINICAL_TRIALS trial_result · 2009-01-15Clinical Trial Update: Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans
This completed clinical trial evaluated enrollment, care dynamics, and patient outcomes in New York State Medicaid HIV Special Needs Plans. …
-
CLINICAL_TRIALS research · 2009-01-14Clinical Trial Update: Family Access to Care Study (FACS)
The Family Access to Care Study (FACS), sponsored by Memorial Sloan Kettering Cancer Center, has completed. It concerns access to care for i…
-
FDA approval · 2009-01-13FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) submitted by Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) [Phase 2]
This document reports an update on a Phase 2 trial evaluating anti-herpetic treatment for genital ulcers (ANRS 1212) and its effect on HIV a…
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN) [Phase 3]
This is an update on a Phase 3 randomized trial (ANRS 1269 TRIVACAN) evaluating structured treatment interruption of HAART in HIV-infected a…
-
FDA approval · 2008-12-19FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Ziagen (abacavir sulfate) submitted by ViiV Healthcare Company.
-
FDA approval · 2008-12-18FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2008-11-25FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company. Details on the specific changes …
-
FDA approval · 2008-11-25FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron.
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
A clinical trial update reporting on the efficacy and safety of MK-0518 (raltegravir) in treatment-experienced HIV-1 infected adults with he…
-
FDA approval · 2008-11-25FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron.
-
CLINICAL_TRIALS research · 2008-11-24Clinical Trial Update: Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus [Phase 4]
This clinical trial update discusses a Phase 4 study evaluating topical cyclosporine for dry eye in HIV-infected individuals.
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy [Phase 4]
A Phase 4 trial evaluating adherence effects and clinical outcomes of Kaletra-based HIV therapy has been terminated.
-
FDA approval · 2008-11-04FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, indicating changes to i…
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only [Phase 4]
Phase 4 study evaluating replacement of nucleoside/nucleotide reverse transcriptase inhibitors with nevirapine in HIV patients on triple the…
-
FDA approval · 2008-10-24FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) by Merck Sharp & Dohme LLC. The approval updates the product’s indic…
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy [Phase 4]
This Phase 4 randomized trial compares three regimens to prevent tuberculosis in HIV-infected patients with anergy; the study has completed.
-
FDA approval · 2008-10-21FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP. This action represents an FDA regulatory update r…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects [Phase 1]
This Phase 1 trial compares once-daily and twice-daily dosing of abacavir in HIV-infected adults, assessing safety, tolerability, and pharma…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Pharmacokinetic Study Of EPZICOM Tablet [Phase 4]
A Phase 4 pharmacokinetic study of EPZICOM (abacavir/lamivudine) in HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
A completed clinical trial evaluating management of HIV-1-infected patients who test positive for the HLA-B*5701 genetic marker.
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults [Phase 2]
A Phase 2 trial evaluating Tucaresol as an add-on to HAART in adults with chronic HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-09Clinical Trial Update: Efficacy of Influenza Vaccine in HIV Infected Adults [Phase 4]
A Phase 4 clinical trial evaluated the efficacy of the influenza vaccine in adults with HIV infection; the study has completed.